Cancer charity founder and cancer genetics pioneer honoured at ICR graduation ceremony 22 Mar 2024 The ICR honoured the founder of CRIS Cancer Foundation, Lola Manterola, and cancer genetics researcher, Professor Sir Bruce Ponder, with honorary degrees at their annual graduation and awards ceremony. Find out more Show/Hide
New drug could unlock benefits of immunotherapy for more patients 27 Feb 2024 A new drug could offer a powerful way to sensitise tumours to immunotherapy, a new trial suggests. Find out more Show/Hide
Immunotherapy shows promise as a kinder first-line treatment for advanced head and neck cancers 04 Oct 2023 Immunotherapy can extend the response of some head and neck tumours to treatment, maintaining the anti-tumour effects and preventing them from growing or spreading for longer, a study reports. Find out more Show/Hide
New head and neck cancer radiotherapy technique could deliver more robust treatment plan in shorter time on MR Linac 23 May 2022